Eagle Pharmaceuticals, Inc. (EGRX)

Eagle Pharmaceuticals Market Cap

Eagle Pharmaceuticals has a market cap or net worth of $45.06 million as of May 31, 2024. Its market cap has decreased by -83.55% in one year.

• Market Cap: 45.06M
• Enterprise Value: 99.90M
• 1-Year Change: -83.55%
• Ranking: #4619
• Category: Nano-Cap
• Stock Price: $3.47

Market Cap Chart

Since February 12, 2014, Eagle Pharmaceuticals's market cap has decreased from $178.40M to $45.06M, a decrease of -74.74%. That is a compound annual growth rate of -12.50%.

Market Cap History

Date	Market Cap	% Change
May 31, 2024	45.10M	1.35%
May 30, 2024	44.50M	2.53%
May 29, 2024	43.40M	-14.73%
May 28, 2024	50.90M	4.73%
May 24, 2024	48.60M	0.41%
May 23, 2024	48.40M	-2.22%
May 22, 2024	49.50M	-12.85%
May 21, 2024	56.80M	-5.18%
May 20, 2024	59.90M	-3.07%
May 17, 2024	61.80M	0.16%
May 16, 2024	61.70M	3.01%
May 15, 2024	59.90M	-1.16%
May 14, 2024	60.60M	3.77%
May 13, 2024	58.40M	-1.02%
May 10, 2024	59.00M	-2.48%
May 9, 2024	60.50M	-1.94%
May 8, 2024	61.70M	-
May 7, 2024	61.70M	3.87%
May 6, 2024	59.40M	3.66%
May 3, 2024	57.30M	0.35%
May 2, 2024	57.10M	4.96%
May 1, 2024	54.40M	2.45%
Apr 30, 2024	53.10M	0.95%
Apr 29, 2024	52.60M	-2.59%
Apr 26, 2024	54.00M	-2.00%

View and export this data all the way back to 2014. Sign Up Today.

Related Stocks

Company	Market Cap
Ocean Biomedical	48.51M
Kronos Bio	47.32M
Lucid Diagnostics	47.08M
Cytosorbents	46.70M
Envoy Medical	46.26M
Aligos Therapeutics	45.97M
Gain Therapeutics	45.85M
IN8bio	45.85M